Related references
Note: Only part of the references are listed.Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study
Oliver Ottmann et al.
BLOOD (2007)
KLF4 suppresses transformation of pre-B cells by ABL oncogenes
Michael G. Kharas et al.
BLOOD (2007)
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia
Brian J. Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias
Moshe Talpaz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation
Andrea Hoelbl et al.
BLOOD (2006)
Regulation of interleukin 7-dependent immunoglobulin heavy-chain variable gene rearrangements by transcription factor STAT5
E Bertolino et al.
NATURE IMMUNOLOGY (2005)
Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML):: evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides
KJ Aichberger et al.
BLOOD (2005)
Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis
S Koschmieder et al.
BLOOD (2005)
Treatment of Philadelphia chromosome-positive acute lymphocytic leukemia with hyper-CVAD and imatinib mesylate
DA Thomas et al.
BLOOD (2004)
Transgenic targeting with regulatory elements of the human CD34 gene
HS Radomska et al.
BLOOD (2002)
BCL-xL and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases
C Greider et al.
ONCOGENE (2002)
The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells
A Klejman et al.
EMBO JOURNAL (2002)
Complementary functions of the antiapoptotic protein A1 and serine/threonine kinase pim-1 in the BCR/ABL-mediated leukemogenesis
M Nieborowska-Skorska et al.
BLOOD (2002)
Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells
U Klein et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia
A Rosenwald et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
BCR-ABL and interleukin 3 promote haematopoietic cell proliferation and survival through modulation of cyclin D2 and p27Kip1 expression
Y Parada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Bcl-x and bax regulate mouse primordial germ cell survival and apoptosis during embryogenesis
EB Rucker et al.
MOLECULAR ENDOCRINOLOGY (2000)
Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-XL
M Horita et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Reversibility of acute B-cell leukaemia induced by BCR-ABL1
CS Huettner et al.
NATURE GENETICS (2000)
Share Paper
